Disparities Exist in Use of Obesity-Management Medications
THURSDAY, Jan. 2, 2025 -- Racial and ethnic disparities are seen in the use of obesity-management medications, according to a study published online Dec. 17 in the Journal of Racial and Ethnic Health Disparities.
Kimberly Narain, M.D., M.P.H., Ph.D., from the University of California, Los Angeles, and Christopher Scannell, M.D., Ph.D., from the University of Southern California in Los Angeles, assessed racial and ethnic differences in the utilization of obesity-management medications among clinically eligible individuals. The analysis included data from the Medical Expenditure Panel Survey (2011 to 2016, 2018, and 2020) for adult participants with a body mass index ≥30 kg/m2 and individuals with a body mass index ≥27 kg/m2 with one or more weight-related conditions.
The researchers found that Asian (adjusted odds ratio, 0.36), Black (adjusted odds ratio, 0.51), and Hispanic individuals (adjusted odds ratio, 0.70) had significantly lower odds of utilizing obesity-management medications compared with White individuals. Among Black and Hispanic individuals, factors partially accounting for these disparities included lower levels of education, lack of health insurance, and higher levels of public health insurance.
"These findings call for the continued exploration of the utilization and perception toward the ever evolving and modernizing obesity medication market," the authors write. "Understanding the perceptions of all populations toward emerging and popularized treatment options is essential to minority health."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Features of Immunesenescence Present in Early Stages of Rheumatoid Arthritis
THURSDAY, Sept. 11, 2025 -- Some features of immunesenescence are present in the very early stages of rheumatoid arthritis (RA), according to a study published online Sept. 3 in...
Urine Biomarker Panel Sensitive, Specific for Prostate Cancer Diagnosis
THURSDAY, Sept. 11, 2025 -- A urine-based biomarker panel has high accuracy for diagnosing prostate cancer (PCa), according to a study published in the September issue of...
Hospitals Vary in Their Definition of Blood Culture Contamination
THURSDAY, Sept. 11, 2025 -- U.S. hospitals vary in how they define blood culture contamination (BCC), according to a study published online July 11 in the Journal of Clinical...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.